Anti-Mouse CCL5 Antibody (R6G9)

Cat. No.: HY-P991753 Pureza: 97.24%: Ficha de datos
COA

SDS

FAQs
Technical Support

Anti-Mouse CCL5 Antibody (R6G9) reacts with mouse CCL5 that can neutralize CCL5 both in vitro and in vivo. Recommend Isotype Controls: Mouse IgG1 kappa, Isotype Control (HY-P99977).

Para uso exclusivo en investigación. No vendemos a pacientes.

Anti-Mouse CCL5 Antibody (R6G9) Estructura química

Tamaño	Stock	Cantidad
1 mg	En stock	Estimated Time of Arrival: December 31
5 mg	En stock	Estimated Time of Arrival: December 31
10 mg	En stock	Estimated Time of Arrival: December 31
50 mg	Obtener un presupuesto
100 mg	Obtener un presupuesto

or Consulta para venta a granel

* Seleccione Cantidad antes de agregar artículos.

This product is a controlled substance and not for sale in your territory.

Recomendaciones destacadas

•Related Screening Libraries:

•Related Small Molecules:

•Related Proteins:

Ver todos los productos específicos de isoformas CXCR:

Ver todas las isoformas

CXCR CXCR1 CXCR2 CXCR3 CXCR4 CXCR7 CXCR6

Actividad biológica
Pureza y Documentación
Referencias
Revisión del cliente

Descripciòn	Anti-Mouse CCL5 Antibody (R6G9) reacts with mouse CCL5 that can neutralize CCL5 both in vitro and in vivo. Recommend Isotype Controls: Mouse IgG1 kappa, Isotype Control (HY-P99977)^[1]^[2].
Isotype	Mouse IgG1 kappa
Recommend Isotype Controls	Mouse IgG1 kappa, Isotype Control
Species Reactivity	Mouse
IC₅₀ & Target	CCL5
Gene ID	20304 [NCBI]
Accession	P30882
Application	in vivo neutralization of CCL5; in vitro neutralization of CCL5; Functional assay; ELISA
Conjugated	Unconjugated
Reconsititution	The product can be reconstituted/diluted with sterile PBS or saline.
Appearance	Liquid
Color	Colorless to light yellow
Formulation	Please refer to the lot-specific COA for specific buffer information.
Almacenamiento	Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación	Purity: 97.24% Select Batch: Ficha de datos (256 KB) SDS (251 KB) COA (231 KB) SDS-PAGE (93 KB) SEC-HPLC (136 KB) Inhibitory Antibodies User Guide (603 KB)
Referencias	[1]. Villegas-Mendez A, et al. WSX-1 signalling inhibits CD4⁺ T cell migration to the liver during malaria infection by repressing chemokine-independent pathways. PLoS One. 2013 Nov 7;8(11):e78486. [Content Brief] [2]. Jens Eberlein, et al. Chemokine Signatures of Pathogen-Specific T Cells I: Effector T Cells. J Immunol. 2020 Oct 15;205(8):2169-2187. [Content Brief]